The role of CFTR mutations in asthma

Canadian Respiratory Journal

Volumn 19, Issue 1, 2012, Pages 44-45

  Sandford, Andrew J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 8; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ASTHMA; BRONCHIECTASIS; BRONCHUS HYPERREACTIVITY; CAUCASIAN; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EDITORIAL; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; LUNG FUNCTION; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; RISK; TH2 CELL;

EID: 84860536505     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/267251     Document Type: Editorial

References (32)

1. Warner JO, Norman AP, Soothill JF. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet 1976;1:990-1.
2. Gyurkovits K, Markus V, Bittera I. Cystic-fibrosis heterozygosity in childhood bronchial asthma. Lancet 1977;1:203. (Pubitemid 8020189)
3. Davis PB. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis 1984;129:911-4. (Pubitemid 14111745)
4. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis. Nat Med 1995;1:703-5.
5. Mennie M, Gilfillan A, Brock DJ, Liston WA. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1995;1:978-9.
6. Douros K, Loukou I, Doudounakis S, Tzetis M, Priftis KN, Kanavakis E. Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations. Int J Clin Exp Med 2008;1:345-9.
7. de Cid R, Chomel JC, Lazaro C, et al. CFTR and asthma in the French EGEA study. Eur J Hum Genet 2001;9:67-9. (Pubitemid 32124438)
8. Dahl M, Tybjærg-Hansen A, Lange P, Nordestgaard BG. ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998;351:1911-3. (Pubitemid 28297446)
9. Dahl M, Nordestgaard BG, Lange P, Tybjærg-Hansen A. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. J Allergy Clin Immunol 2001;107:818-23. (Pubitemid 32436915)
10. Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 2004;37:393-9. (Pubitemid 38620060)
11. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Høiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000;108:329-35. (Pubitemid 30456361)
12. Pignatti PF, Bombieri C, Marigo C, Benetazzo M, Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 1995;4:635-9.
13. Gervais R, Lafitte JJ, Dumur V, et al. Sweat chloride and DF508 mutation in chronic bronchitis or bronchiectasis. Lancet 1993;342:997. (Pubitemid 23305526)
14. Poller W, Faber JP, Scholz S, Olek K, Muller KM. Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course. Klinische Wochenschrift 1991;69:657-63.
15. Dumur V, Lafitte JJ, Gervais R, et al. Abnormal distribution of cystic fibrosis DF508 allele in adults with chronic bronchial hypersecretion. Lancet 1990;335:1340. (Pubitemid 20186404)
16. Entzian P, Muller E, Boysen A, Artlich A, Schwinger E, Schlaak M. Frequency of common cystic fibrosis gene mutations in chronic bronchitis patients. Scand J Clin Lab Invest 1995;55:263-6.
17. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000;117:286S-91S. (Pubitemid 30326996)
18. Stankovic M, Nikolic A, Divac A, et al. The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population. Genet Test 2008;12:357-62.
19. Gasparini P, Savoia A, Luisetti M, Peona V, Pignatti PF. The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1990;2:297-9.
20. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study. Respir Res 2005;6:113.
21. Divac A, Nikolic A, Mitic-Milikic M, et al. High frequency of the R75Q CFTR variation in patients with chronic obstructive pulmonary disease. J Cyst Fibros 2004;3:189-91. (Pubitemid 39194075)
22. Wilk JB, Chen TH, Gottlieb DJ, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009;5:e1000429.
23. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010;42:45-52.
24. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010;42:36-44.
25. Obeidat M, Wain LV, Shrine N, et al. A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One 2011;6:e19382.
26. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet 2009;5:e1000421.
27. Cho MH, Boutaoui N, Klanderman BJ, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010;42:200-2.
28. Kong X, Cho MH, Anderson W, et al. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med 2010.
29. Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010;363:1211-21.
30. Hirota T, Takahashi A, Kubo M, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011;43:893-6.
31. Torgerson DG, Ampleford EJ, Chiu GY, et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011;43:887-92.
32. Goodwin J, Spitale N, Yaghi A, Dolovich M, Nair P. Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis. Can J Respir 2012;19:46-8.